ETERNAL Boosting the reduction of the environmental impact of pharmaceutical products throughout their entire life cycle.
- Coordinator
- Aimplas - Asociacion De Investigacion De Materiales Plasticos Y Conexas, Spain
- Runs
- 1 September 2022 to 31 August 2026
- Status
- Running
- EU funding
- €5.9m
- Total cost
- €5.9m
- Partners
- 16 organisations in 7 countries
- Type
- Research and Innovation Action
- Grant agreement
- 101057668
What the project is doing
In the project's own words, from its summary on CORDIS.
ETERNAL aims to contribute to sustainable development of pharmaceutical manufacture, use and disposal, by using and promoting full life cycle approaches covering design, manufacture, usage, and disposal, assessing the environmental risks of not only the API and residues/metabolites, but other chemicals and by-products of the production process. This type of approach is essential to take into consideration the types of green manufacturing approach under consideration by the pharmaceutical industry, as evidenced by the range and scope of case studies being undertaken within ETERNAL.
Specific application of our risk and life cycle assessment approaches to the ETERNAL case studies is a key element of the proposed work and will provide industry and policymakers with key examples of how whole life cycle assessment may be used to evaluate the changes in environmental impacts expected due to the introduction of green manufacturing processes.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Aimplas - Asociacion De Investigacion De Materiales Plasticos Y Conexas | Paterna | Spain | Coordinator |
| Universitaet Fuer Bodenkultur Wien | Wien | Austria | Participant |
| Mybiotech GmbH | Uberherrn | Germany | Participant |
| Universitat Des Saarlandes | Saarbrucken | Germany | Participant |
| Asociacion Espanola De Normalizacion | Madrid | Spain | Participant |
| Asphalion SL | Barcelona | Spain | Participant |
| Iris Technology Solutions, Sociedad Limitada | Cornella de Llobregat | Spain | Participant |
| Laboratorio Reig Jofre SA | Sant Joan Despi | Spain | Participant |
| Enviroeye Engineeing Ltd | Dublin | Ireland | Participant |
| Innovation Commercial Pathways Company Limited by Guarantee | Killarney | Ireland | Participant |
| Aziende Chimiche Riunite Angelini Francesco - A.c.r.a.f. - SpA | Roma | Italy | Participant |
| Universidade De Aveiro | Aveiro | Portugal | Participant |
| Astrazeneca UK Limited | Cambridge | United Kingdom | Associatedpartner |
| Britest Lbg | Oxford | United Kingdom | Associatedpartner |
| Quotient Sciences (alnwick) Limited | Nottingham | United Kingdom | Associatedpartner |
| UK Centre for Ecology & Hydrology | Oxford | United Kingdom | Associatedpartner |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI